Documents
Application Sponsors
ANDA 076934 | ACI HEALTHCARE LTD | |
Marketing Status
Application Products
001 | CONCENTRATE;ORAL | EQ 20MG BASE/ML | 0 | SERTRALINE HYDROCHLORIDE | SERTRALINE HYDROCHLORIDE |
FDA Submissions
| ORIG | 1 | AP | 2006-06-30 | |
LABELING; Labeling | SUPPL | 3 | AP | 2008-01-09 | |
LABELING; Labeling | SUPPL | 4 | AP | 2008-01-09 | |
LABELING; Labeling | SUPPL | 5 | AP | 2008-07-16 | |
LABELING; Labeling | SUPPL | 6 | AP | 2015-11-19 | STANDARD |
LABELING; Labeling | SUPPL | 7 | AP | 2019-04-05 | STANDARD |
Submissions Property Types
TE Codes
CDER Filings
ACI HEALTHCARE LTD
cder:Array
(
[0] => Array
(
[ApplNo] => 76934
[companyName] => ACI HEALTHCARE LTD
[docInserts] => ["",""]
[products] => [{"drugName":"SERTRALINE HYDROCHLORIDE","activeIngredients":"SERTRALINE HYDROCHLORIDE","strength":"EQ 20MG BASE\/ML","dosageForm":"CONCENTRATE;ORAL","marketingStatus":"Discontinued","te":"None","rld":"No","rs":"No"}]
[labels] =>
[originalApprovals] => [{"actionDate":"SERTRALINE HYDROCHLORIDE","submission":"SERTRALINE HYDROCHLORIDE","actionType":"EQ 20MG BASE\/ML","submissionClassification":"CONCENTRATE;ORAL","reviewPriority":"Discontinued","inserts":"[]","notes":">No"}]
[supplements] =>
[actionDate] => 1969-12-31
)
)